A I Minchinton, M R Stratford
Index: Int. J. Radiat. Oncol. Biol. Phys. 12(7) , 1117-20, (1986)
Full Text: HTML
Pharmacokinetic studies were carried out in mice after co-administration of 2-nitroimidazoles with differing prototropic properties: Ro 03-8799, misonidazole, SR 2508, and azomycin. In addition, the distribution of sensitizers in different areas of individual tumors, as well as several normal tissues were measured after intravenous dosing of 0.5 mmol kg-1 (145-56 mg/kg). Although there appeared to be no significant pharmacokinetic interaction between sensitizers after co-administration, there was a significant difference in the distribution of sensitizers within tumors of differing type and size. In small, fast growing SaFa and large, slow growing CaRH tumors, the levels of all sensitizers was relatively constant throughout. However, large fast growing SaFa tumors demonstrated the high degree of variability in the Ro 03-8799 concentration that is seen in the clinic. This may be important in the modelling of human tumors with regard to sensitizer distribution.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
2-Nitroimidazole
CAS:527-73-1 |
C3H3N3O2 |
A (99m)Tc-labeled misonidazole analogue: step toward a (99m)...
2015-03-01 [Cancer Biother. Radiopharm. 30(2) , 79-86, (2015)] |
The synthesis and radiolabeling of 2-nitroimidazole derivati...
2002-06-01 [J. Nucl. Med. 43(6) , 837-50, (2002)] |
The oxygen dependence of the reduction of nitroimidazoles in...
1984-08-01 [Int. J. Radiat. Oncol. Biol. Phys. 10(8) , 1323-6, (1984)] |
Imaging hypoxia and angiogenesis in tumors.
2005-01-01 [Radiol. Clin. North Am. 43(1) , 169-87, (2005)] |
Radiosensitization by misonidazole, pimonidazole and azomyci...
1990-02-01 [Int. J. Radiat. Biol. 57(2) , 361-72, (1990)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved